PLoS One:IFN治疗丙肝对甲状腺功能影响报道不一
Frequency of Thyroid Dysfunctions during Interferon Alpha Treatment of Single and Combination Therapy in Hepatitis C Virus-Infected Patients: A Systematic Review Based Analysis
Hepatology:丙肝肝硬化大多因酗酒导致
Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness.
SVR意味“硬”终点改善
Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronichepatitis C: a prospective study
黄疸且IL28B CT/TT型AHC患者缺乏HCV清除能力
Treatment optimization of and prediction of HCV clearance in patientswith acute HCV infection
对于急性丙型肝炎病毒(HCV)感染(AHC)患者而言,早期起始抗病毒治疗似乎与更高的持续病毒学应答(SVR)率相关。然而,目前在有关AHC的最佳治疗时机、治疗方案以及治疗时长等问题上尚未达到共识。鉴于过半数的AHC患者能够自发康复,早期起始治疗可能会使那些能够实现自发性病毒清除的患者遭受不必要的昂贵治疗。基于上述情况,来自意大利圣乔凡尼罗通多IRCCS Casa Sollievo della Sofferenza Hospital统计中心的Alessandra Mangia等人展开了一项研究,研究结果在线发表于2013年4月15日的《肝脏病学杂志》(Journal of Hepatology)杂志上。作者发现,对于急性丙型肝炎患者,根据无黄疸且IL28B为CT/TT型可预测其缺乏病毒清除能力。